Survival in monoclonal gammopathy of undetermined significance and waldenström macroglobulinemia

Clinical Lymphoma, Myeloma and Leukemia

Volumn 13, Issue 2, 2013, Pages 187-190

  Kristinsson, Sigurdur Y ^a,b   Björkholm, Magnus ^a   Landgren, Ola ^a,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF ICELAND   (Iceland)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bortezomib; Fludarabine; Lymphoplasmacytic lymphoma survival; MGUS; Prognosis; Rituximab; Thalidomide; Treatment; Waldenstr m macroglobulinemia

Indexed keywords

BORTEZOMIB; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; M PROTEIN; MONOCLONAL ANTIBODY; PURINE DERIVATIVE; THALIDOMIDE;

AMYLOIDOSIS; BACTERIAL INFECTION; CAUSE OF DEATH; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; ISCHEMIC HEART DISEASE; LIVER DISEASE; MALIGNANT TRANSFORMATION; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; NETHERLANDS; OVERALL SURVIVAL; PALLIATIVE THERAPY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PROGNOSIS; SURVIVAL RATE; WALDENSTROEM MACROGLOBULINEMIA;

DISEASE PROGRESSION; HUMANS; IMMUNOGLOBULIN M; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; PROGNOSIS; RISK FACTORS; WALDENSTROM MACROGLOBULINEMIA;

EID: 84877601712     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2013.02.010     Document Type: Conference Paper

References (27)

1. S.H. Swerdlow, E. Campo, N.L. Harris WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 4th ed. 2008 IARC Press Lyon
2. S.Y. Kristinsson, M. Björkholm, L.R. Goldin Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden Blood 112 2008 3052 3056
3. J. Waldenström Incipient myelomatosis or 'essential' hyperglobulinemia with fibrinogenopenia: a new syndrome? Acta Med Scand 117 1944 216 247
4. S.P. Treon, L. Xu, G. Yang MYD88 L265P somatic mutation in Waldenström's macroglobulinemia N Engl J Med 367 2012 826 833
5. R.A. Kyle, T.M. Therneau, S.V. Rajkumar Long-term follow-up of IgM monoclonal gammopathy of undetermined significance Blood 102 2003 3759 3764 (Pubitemid 37409398)
6. R.A. Kyle, T.M. Therneau, S.V. Rajkumar A long-term study of prognosis in monoclonal gammopathy of undetermined significance N Engl J Med 346 2002 564 569 (Pubitemid 34438817)
7. C.G. Schaar, S. le Cessie, S. Snijder Long-term follow-up of a population based cohort with monoclonal proteinaemia Br J Haematol 144 2009 176 184
8. H. Gregersen, J. Ibsen, L. Mellemkjoer Mortality and causes of death in patients with monoclonal gammopathy of undetermined significance Br J Haematol 112 2001 353 357 (Pubitemid 32183476)
9. S.Y. Kristinsson, M. Björkholm, T.M. Andersson Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study Haematologica 94 2009 1714 1720
10. R.A. Kyle, T.M. Therneau, S.V. Rajkumar Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later Mayo Clin Proc 79 2004 859 866 (Pubitemid 38879951)
11. R. García-Sanz, S. Montoto, A. Torrequebrada Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases Br J Haematol 115 2001 575 582 (Pubitemid 34019184)
12. P. Morel, M. Monconduit, D. Jacomy Patients with the description of a new scoring system and its validation on 253 other patients Blood 96 2000 852 858
13. R.A. Kyle, J.T. Benson, D.R. Larson Progression in smoldering Waldenstrom macroglobulinemia: long-term results Blood 119 2012 4462 4466
14. P. Morel, A. Duhamel, P. Gobbi International prognostic scoring system for Waldenstrom macroglobulinemia Blood 113 2009 4163 4170
15. S.P. Treon How I treat Waldenström macroglobulinemia Blood 114 2009 2375 2385
16. M.A. Dimopoulos, M.A. Gertz, E. Kastritis Update on treatment recommendations from the fourth International workshop on Waldenstrom's macroglobulinemia J Clin Oncol 27 2009 120 126
17. M.A. Dimopoulos, R. Alexanian, D. Gika Treatment of Waldenstrom's macroglobulinemia with rituximab: prognostic factors for response and progression Leuk Lymphoma 45 2004 2057 2061 (Pubitemid 39232854)
18. T. Facon, M. Brouillard, A. Duhamel Prognostic factors in Waldenström's macroglobulinemia: a report of 167 cases J Clin Oncol 11 1993 1553 1558 (Pubitemid 23228262)
19. G. Merlini, L. Baldini, C. Broglia Prognostic factors in symptomatic Waldenstrom's macroglobulinemia Semin Oncol 30 2003 211 215 (Pubitemid 36506311)
20. M.V. Dhodapkar, J.L. Jacobson, M.A. Gertz Prognostic factors and response to fludarabine therapy in Waldenstrom's macroglobulinemia: an update of a US intergroup trial (SW0G S9003) Semin Oncol 30 2003 220 225 (Pubitemid 36506313)
21. M.A. Dimopoulos, P. Panayiotidis, L.A. Moulopoulos Waldenström's macroglobulinemia: clinical features, complications, and management J Clin Oncol 18 2000 214 226 (Pubitemid 30036355)
22. P.G. Gobbi, R. Bettini, C. Montecucco Study of prognosis in Waldenström's macroglobulinemia: a proposal for a simple binary classification with clinical and investigational utility Blood 83 1994 2939 2945
23. M. Björkholm, E. Johansson, D. Papamichael Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia: a two-institution study Semin Oncol 30 2003 226 230 (Pubitemid 36506314)
24. S.Y. Kristinsson, S. Eloranta, P.W. Dickman Patterns of survival in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: a population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005 Am J Hematol 88 2013 60 65
25. M. Hensel, J. Brust, C. Plöger Excellent long-term survival of 170 patients with Waldenström's macroglobulinemia treated in private oncology practices and a university hospital Ann Hematol 91 2012 1923 1928
26. E. Kastritis, M.C. Kyrtsonis, E. Hatjiharissi No significant improvement in the outcome of patients with Waldenström's macroglobulinemia treated over the last 25 years Am J Hematol 86 2011 479 483
27. S.Y. Kristinsson, O. Landgren, P.W. Dickman Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003 J Clin Oncol 25 2007 1993 1999 (Pubitemid 46972782)